This inventor holds 1 USPTO granted patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovations of David Qin Liu
Introduction: David Qin Liu is an accomplished inventor based in Suffern, NY (US). He has made significant contributions to the field of antifungal treatments through his innovative research and development. His work focuses on harnessing natural products to combat fungal infections effectively.
Latest Patents: David Qin Liu holds a patent for "Antifungal agents derived from Aspergillus fumigatus." This patent details a natural product of Aspergillus fumigatus and specific derivatives thereof, along with a method for treating fungal infections using these agents. His innovative approach has the potential to improve treatment options for patients suffering from fungal infections.
Career Highlights: David is currently employed at Millennium Pharmaceuticals Limited, where he continues to advance his research in pharmaceuticals. His dedication to innovation in the medical field has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations: Throughout his career, David has collaborated with notable colleagues, including Zhi-Dong Jiang and Rex T Gallagher. These partnerships have fostered a collaborative environment that enhances the development of new treatments and technologies.
Conclusion: David Qin Liu's contributions to antifungal research exemplify the impact of innovation in medicine. His patent and ongoing work at Millennium Pharmaceuticals Limited highlight the importance of scientific advancements in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile